))
Episode 12: The Future of the Drug Industry
Manage episode 337444522 series 3381207
A tartalmat a Gunnar Esiason biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Gunnar Esiason vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Dr. Bill Smith, a visiting fellow in the life sciences at the Boston-based think tank, Pioneer Institute, and former drug industry veteran, joins the State of Health to talk about the evolving market dynamics in the drug industry starting with the Orphan Drug Act and the industry's rush into therapeutic development for rare diseases. In this episode, Gunnar presses Dr. Smith on the sustainability of high list prices and burden for the insurance industry. Dr. Smith also talks about rising coinsurance rates as a barrier to patient access. The show concludes with Dr. Smith's hopes for the future of drug development and evolving market dynamic.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
23 epizódok
Megosztás
